FARINES ALIMENTAIRES UTILES DANS LA RÉDUCTION DE LA GLYCÉMIE, DANS LE TRAITEMENT DU SYNDROME MÉTABOLIQUE, DANS LA RÉDUCTION DU CHOLESTÉROL ET/OU DANS LE TRAITEMENT DU DIABÈTE DE TYPE 2
The present invention relates to a food flour or mixture of food flours, wherein the flours are selected from wheat flour, rye flour, buckwheat flour, rice flour, barley flour, oatmeal, corn flour or combinations thereof, preferably wheat flour, more preferably soft wheat flour, characterized in that it comprises a quantity of soluble fibre rich in immediately available soluble pentosans, among which arabinoxylans, ranging from 3 g to 4.5 g with respect to 100 g of flour or mixture of flours, preferably wheat flour, and in that a quantity ranging from 0.09 g to 0.25 g of the total weight of the soluble fibre has a molecular size of the polysaccharide chains lower than 5 kDa. The soluble fibre is preferably present in the mixture of the invention in a quantity ranging from 3.2 g to 3.5 g with respect to 100 g of flour or mixture of flours of the invention, preferably wheat flour, and/or the percentage of soluble fibre having a molecular size of the polysaccharide chains lower than 5 kDa ranges from 0.09 g to 0.19 g of the total weight of the soluble fibre. Even more preferably, the quantity of immediately available soluble pentosans, among which arabinoxylans, present in the flour or mixture of food flours of the invention, preferably wheat flour, ranges from 0.43 g to 0.58 g with respect to 100 g of flour or mixture of flours of the invention, preferably wheat flour. The flour or mixture of flours of the invention, preferably wheat flour, as defined above, are useful in the reduction of postprandial glycemia in normoglycemic subjects, in the treatment of metabolic syndrome, in the reduction of cholesterol or in the treatment of type 2 diabetes.
